Literature DB >> 22484779

Novel oral anticoagulants in atrial fibrillation: will the benefit outweigh the cost?

John Goudevenos1, Athanasios Pipilis, Panos Vardas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484779

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN: 1109-9666


× No keyword cloud information.
  1 in total

1.  Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting.

Authors:  Kostas Athanasakis; Eleftheria Karampli; Dimitrios Tsounis; Aikaterini Bilitou; John Kyriopoulos
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.